Sandip Roy

Wildcard
DISC Type : csi

Vice President, Head of Global Regulatory Affairs at Keenova

Basking Ridge, New Jersey, United States

Overview

Sandip Roy is the Vice President and Head of Global Regulatory Affairs at Keenov, leveraging over two decades of experience in the biopharmaceutical industry. He holds a Ph. D. from the University of South Florida and has held senior leadership roles at Merck, Organon, and Mallinckrodt, specializing in global regulatory strategy.

He co-authored a clinical study on the pharmacokinetics of combining Amantadine and Oseltamivir, highlighting his deep expertise in drug interactions and pandemic influenza preparedness.

Personality Overview

Curious But Skeptical

ROI Driven

Friendly But Slow

They are often friendly and nice, but can sometimes suprise you with their piercing questions  They typically tend to be late adopters even when they seem friendly and excited about what you have to sell They are unlikely to ever become strong champions even when the conversations are going well; you should focus on cultivating other champions

Topics They Care About

Global Regulatory Strategy
His entire career is focused on leading global regulatory affairs for major pharmaceutical companies like Merck, Organon, and Keenov.
Pharmaceutical Development
He has extensive experience across the drug development lifecycle, from clinical safety and pharmacovigilance to global product strategy.
Infectious Diseases
Previously served as an Executive Director at Merck, where he focused on global regulatory affairs and clinical safety for vaccines and infectious diseases.

Media Appearances

Sandip has no verified media appearances

Work History

11-2025
Vice President, Head of Global Regulatory Affairs at Keenova
10-2022 - 11-2025
Vice President, Global Head of Regulatory Affairs & Safety/ Pharmacovigilance at Mallinckrodt Pharmaceuticals
6-2021 - 10-2022
Head of US Regulatory Affairs & Global Product Strategy at Organon at Organon
10-2018 - 6-2021
Associate Vice President, Therapeutic Area Head of General Medicine, Global Regulatory Affairs at Merck
8-2015 - 10-2018
Executive Director, Global Regulatory Affairs & Clinical Safety, Vaccines and Inectious Disease at Merck

Education

1994 - 1997
Fellowship from University of Chicago
1989 - 1993
Ph.D. from University of South Florida

More Information

Social Presence :

Prographics :

Exp : 22 Location : Basking Ridge, New Jersey, United States Job Level : Senior Designation : Vice President, Head of Global Regulatory Affairs at Keenova
URL has been copied!

Insights For Selling To Sandip

During A Call Or A Meeting

DO's

  • Be prepared for a lot of questions, answer them objectively
  • Help them realize that there is no personal risk in making this decision
  • Persuade objectively how your product will help them achieve their goals

DONT's

  • Do not sound overly eager, modulate your energy levels especially if you are generally enthusiastic
  • Don’t overhype the product/pitch, keep it measured
  • Avoid phrases like ‘trust me’, ‘you will just love it’ etc.

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Sandip is

  • Clear proof of product value matters to them, followed by others' testimonials and rapport.
  • Will you ever get a clear answer from Sandip

  • They are likely to give you a clear answer without taking you around in circles. However, if you share a good relationship, they might not be so forthcoming.

Insights For Deal Planning

    How fast (or slow) will Sandip move?

  • They like to perform full analysis and can take time to make any decision.
  • Can Sandip take some risk or not?

  • They weigh all decisions systematically and are unlikely to take many risks.

You And Sandip

Personality Compatibility


Other Keenova Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.